Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK2982772 in moderate to severe rheumatoid arthritis
NCT02858492Phase 2Completed
- Sponsor
- GSK
- Start
- Oct 2016
- Primary completion
- Oct 2018
- Modality
- Orthosteric Ligands
- Countries
- 6
01
Overview
A Phase 2 trial of GSK2982772 in rheumatoid arthritis (RA), sponsored by GSK. Started Oct 2016; status: completed.
02
Drugs
GSK2982772
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02858492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02858492.